Company profile

Abbisko Therapeutics

2256 · HKEX

Public Market Listing

2256HKEX

HKEX primary exchange listing

Live quotes, historical charts, and market capitalization for Abbisko Therapeutics are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(3 total)
3Total Assets
0Approved
0Phase 3 / Filed
3Phase 1–2 / Early
1Diseases
Showing 3 of 3 assets
Target & Modality
ABSK043
Phase 2
PD-1/PD-L1 interactionMonoclonal antibody
Non-Small Cell Lung Cancer
ABSK061
Phase 2
FGFR2 / FGFR3Small molecule
Non-Small Cell Lung Cancer
ABSK112
Phase 1
EGFR exon 20 insertionSmall molecule
Non-Small Cell Lung Cancer

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.